Viewing Study NCT07218692


Ignite Creation Date: 2025-12-24 @ 3:56 PM
Ignite Modification Date: 2026-04-07 @ 12:12 AM
Study NCT ID: NCT07218692
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-10-20
First Post: 2025-10-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy
Sponsor: City of Hope Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module